JSBMR’s Guidelines Recommend Alendronate, Risedronate as First-Line Therapies for Steroid-Induced Osteoporosis Based on Available Data

The Japanese Society for Bone and Mineral Research (JSBMR) announced the 2014 edition of its “Guidelines on the Management and Treatment of Glucocorticoid-induced Osteoporosis” on April 17. This is the JSBMR’s first revision of its guidelines since their original publication...read more